Susquehanna International Group
OLMA icon

Susquehanna International Group’s Olema Pharmaceuticals OLMA Stock Holding History

Susquehanna International Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.19M Buy
549,300
+60,400
+12% +$1.34M ﹤0.01% 3420
2025
Q4 		$12.2M Buy
+488,900
New +$8.7M ﹤0.01% 2796
2025
Q1 		– Sell
-81,000
Closed -$472K – 13175
2024
Q4 		$472K Buy
81,000
+19,800
+32% +$198K ﹤0.01% 8813
2024
Q3 		$731K Buy
61,200
+35,900
+142% +$459K ﹤0.01% 7550
2024
Q2 		$274K Buy
25,300
+3,200
+14% +$34.7K ﹤0.01% 9655
2024
Q1 		$250K Buy
22,100
+4,300
+24% +$55.5K ﹤0.01% 10118
2023
Q4 		$250K Sell
17,800
-64,400
-78% -$865K ﹤0.01% 10217
2023
Q3 		$1.02M Buy
82,200
+55,500
+208% +$566K ﹤0.01% 6598
2023
Q2 		$241K Buy
26,700
+13,200
+98% +$79.7K ﹤0.01% 9886
2023
Q1 		$46.8K Sell
13,500
-7,700
-36% -$31.4K ﹤0.01% 11720
2022
Q4 		$51.9K Sell
21,200
-22,400
-51% -$65.3K ﹤0.01% 11373
2022
Q3 		$120K Sell
43,600
-26,300
-38% -$112K ﹤0.01% 11521
2022
Q2 		$284K Buy
69,900
+45,500
+186% +$144K ﹤0.01% 9717
2022
Q1 		$104K Sell
24,400
-62,000
-72% -$342K ﹤0.01% 11878
2021
Q4 		$809K Buy
86,400
+76,600
+782% +$1.59M ﹤0.01% 7851
2021
Q3 		$270K Buy
+9,800
New +$265K ﹤0.01% 10823

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Susquehanna International Group's OLMA Position: Q1 2026 in Review

Susquehanna International Group increased its Olema Pharmaceuticals (OLMA) stake by 2,447% in Q1 2026, buying an estimated $6.11M and bringing the position to 285,882 shares worth $4.26M. The position accounts for ﹤0.01% of the portfolio, ranked #4536.

Susquehanna International Group first reported a position in OLMA in Q4 2020 and has held it in 19 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Susquehanna International Group held 285,882 shares of Olema Pharmaceuticals worth $4.26M as of Q1 2026.
  • Susquehanna International Group bought 274,658 Olema Pharmaceuticals shares in Q1 2026, an estimated $6.11M.
  • Olema Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4536 holding.
  • Susquehanna International Group first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 19 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.